Annals of the Rheumatic Diseases

Annals of the Rheumatic Diseases (ANN RHEUM DIS) is a premier, peer-reviewed medical journal dedicated to the highest quality original research in the field of rheumatology. Published by BMJ Group, the journal boasts an exceptional 2026 Impact Factor of 24.000 and is consistently ranked in the top Q1 quartile of its category, reflecting its status as one of the most influential and highly cited publications in clinical medicine. The journal’s scope encompasses the full spectrum of rheumatic and musculoskeletal diseases, including rheumatoid arthritis, osteoarthritis, systemic lupus erythematosus, spondyloarthritis, gout, and pediatric rheumatic conditions. It features a diverse array of article types, including original research articles, concise reports, extended reports, clinical and epidemiological studies, systematic reviews, and viewpoint editorials. Additionally, it publishes recommendations and guidelines from leading international task forces. The primary target audience comprises academic rheumatologists, clinical researchers, immunologists, orthopedic surgeons, and allied health professionals seeking cutting-edge evidence to inform clinical practice and translational science. Notable features include a robust open access option for authors, ensuring global dissemination of critical findings, and a rigorous, fast-track peer-review process designed to accelerate the publication of high-impact discoveries. With its unwavering commitment to scientific excellence and its ability to shape clinical paradigms, Annals of the Rheumatic Diseases stands as an indispensable resource for advancing the understanding, diagnosis, and treatment of rheumatic diseases worldwide.